Posted by Michael Wonder on 29 May 2018
EMA publishes agenda for 28-31 May CHMP meeting
28 May 2018 - The EMA has published a draft agenda for this week's CHMP meeting.
The CHMP is due to issue initial opinions for the following technologies:
- Erenumab
- Caplacizumab
- Etiplersen
- Adalimumab
- Metreleptin
- Nitisinone
- Brexpiprazole
- Inotersen
- Trastuzumab
- Vonicog alfa
